By Emeritus Professor Andrew Lloyd

Journal articles

Vollmer-Conna U; Piraino B; Lloyd AR, 2013, '26. Polymorphisms in both immune and behavioural genes affect mood as part of the acute sickness response to infection', Brain, Behavior, and Immunity, 32, pp. e8 - e8, http://dx.doi.org/10.1016/j.bbi.2013.07.038

Vollmer-Conna U; Gunawardane U; Patel V; Cvejic E; Lloyd AR, 2013, '39. Vagus nerve activity, a good night’s sleep, and recovery from acute infection', Brain, Behavior, and Immunity, 32, pp. e11 - e12, http://dx.doi.org/10.1016/j.bbi.2013.07.051

Cameron B; Galbraith S; Li H; Lloyd A; HITS investigators , 2013, 'Correlates and characteristics of hepatitis C virus-specific T-cell immunity in exposed uninfected high-risk prison inmates', Journal of Viral Hepatitis, 20, pp. e96 - e106, http://dx.doi.org/10.1111/jvh.12016

Post J; Arain A; Lloyd AR; Grebely J; Dore G, 2013, 'Enhancing Assessment and Treatment Hepatitis C in the Custodial Setting', Clinical Infectious Diseases, 57, pp. S70 - S74, http://dx.doi.org/10.1093/cid/cit264

Lloyd AR, 2013, 'Fatigue after infection: aetiology and pathophysiology', MICROBIOLOGY AUSTRALIA, 34, pp. 142 - 144, http://dx.doi.org/10.1071/MA13047

Chang CC; Crane M; Zhou J; Mina M; Post JJ; Cameron BA; Lloyd AR; Jaworowski A; French MA; Lewin SR, 2013, 'HIV and co-infections', Immunological Reviews, 254, pp. 114 - 142, http://dx.doi.org/10.1111/imr.12063

Sugden PB; Pham TN; Ratnarajah S; Cameron B; Bull R; White PA; Michalak TI; Lloyd AR, 2013, 'Rare occurrence of occult hepatitis C virus in apparently uninfected injecting drug users: a two-centre, masked, case-control study', J Viral Hepat, 20, pp. 725 - 728, http://dx.doi.org/10.1111/jvh.12098

Goldstein D; Bennett BK; Webber K; Lloyd AR, 2012, 'Reply to A. Giacalone et al', Journal of Clinical Oncology, 30, pp. 4175 - 4176, http://dx.doi.org/10.1200/JCO.2012.45.6269

Mccredie L; Luciani F; Teutsch S; Amin J; Topp L; Dolan K; Lloyd A, 2012, 'BLOODY PRISONS: INCIDENCE OF RISK BEHAVIOURS AND HEPATITIS C VIRUS TRANSMISSION IN AN AUSTRALIAN PRISONER COHORT', DRUG AND ALCOHOL REVIEW, 31, pp. 57 - 57, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000311236700175&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hovey E; de Souza P; Marx G; Parente P; Rapke T; Hill A; Bonaventura A; Michele A; Kraft P; Lloyd A, 2012, 'PHASE III, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF MODAFINIL FOR FATIGUE IN PATIENTS TREATED WITH DOCETAXEL-BASED CHEMOTHERAPY', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 8, pp. 44 - 44, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000306960100015&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hovey EJ; De Souza PL; Marx GM; Rapke T; Parente P; Hill A; Bonaventura A; Michele A; Craft PS; Abdi EA; Lloyd AR, 2012, 'Modafinil for fatigue associated with docetaxel-based chemotherapy: A randomized controlled trial.', Journal of Clinical Oncology, 30, pp. e15152 - e15152, http://dx.doi.org/10.1200/jco.2012.30.15_suppl.e15152

Bennett BK; Lloyd AR; Webber K; Friedlander M; Goldstein D, 2012, 'Predictors of resilience in women treated for breast cancer: A prospective study.', Journal of Clinical Oncology, 30, pp. 9044 - 9044, http://dx.doi.org/10.1200/jco.2012.30.15_suppl.9044

Sugden PB; Cameron B; Bull RA; White PA; Lloyd AR, 2012, 'Occult infection with hepatitis C virus: friend or foe?', , http://dx.doi.org/10.1038/icb.2012.20

Hovey EJ; De Souza PL; Marx GM; Parente P; Rapke T; Hill A; Bonaventura A; Michele A; Craft PS; Abdi EA; Lloyd AR, 2012, 'Modafinil for fatigue associated with docetaxel-based chemotherapy: A randomized controlled trial', JOURNAL OF CLINICAL ONCOLOGY, 30, http://dx.doi.org/10.1200/jco.2012.30.5_suppl.211

Hovey EJ; De Souza PL; Marx GM; Parente P; Rapke T; Hill A; Bonaventura A; Michele A; Craft PS; Abdi EA; Lloyd AR, 2012, 'Modafinil for fatigue associated with docetaxel-based chemotherapy: A randomized controlled trial.', J Clin Oncol, 30, pp. 211, http://www.ncbi.nlm.nih.gov/pubmed/27967925

Nguyen N; Luciani F; Cameron B; Keoshkerian E; Zekry A; Lloyd A, 2012, '801 T CELLS CO-EXPRESSING CCR2, CCR5, CXCR3, AND CXCR6 ARE PREFERENTIALLY ENRICHED IN THE HCV-INFECTED LIVER', Journal of Hepatology, 56, pp. S313 - S313, http://dx.doi.org/10.1016/s0168-8278(12)60813-7

Van Der Meer J; Lloyd AR, 2012, 'A controversial consensus – comment on article by Brodericket al', Internal Medicine Journal, 271, pp. 29 - 31, http://dx.doi.org/10.1111/j.1365-2796.2011.02468.x

Keoshkerian E; Helbig K; Beard M; Zaunders J; Seddiki N; Kelleher AD; Hampartzoumian T; Zekry A; Lloyd AR, 2012, 'A novel assay for detection of hepatitis C virus-specific effector CD4(+) T cells via co-expression of CD25 and CD134', Journal of Immunological Methods, 375, pp. 148 - 158, http://dx.doi.org/10.1016/j.jim.2011.10.004

Goldstein D; Bennett BK; Webber K; Boyle F; De Souza P; Wilcken NRC; Scott E; Toppler R; Murie P; O''Malley L; Mccourt J; Friedlander M; Hickie IB; Lloyd AR, 2012, 'Cancer-related fatigue in women with breast cancer: outcomes of a 5 year prospective cohort study.', Journal of Clinical Oncology, 30, pp. 1805 - 1812, http://dx.doi.org/10.1200/JCO.2011.34.6148

Scott GM; Chow SS; Craig ME; Pang CN; Hall B; Wilkins MR; Jones C; Lloyd AR; Rawlinson WD; hall B, 2012, 'Cytomegalovirus infection during pregnancy with maternofetal transmission induces a proinflammatory cytokine bias in placenta and amniotic fluid', Journal of Infectious Diseases, 205, pp. 1305 - 1310, http://dx.doi.org/10.1093/infdis/jis186

Grebely J; Matthews GV; Petoumenos K; Yeung B; Day C; Lloyd AR; Beek IV; Kaldor JM; Hellard M; Dore GJ; Haber PS; Alavi M; Van Beek I; Amin J; Dolan K; Rawlinson W; Flynn J; Marks P; Acraman B; Bloch M; Li H; Madden A; George J, 2012, 'Effect of pegylated interferon-a-2a treatment on mental health during recent hepatitis C virus infection', Journal of Gastroenterology and Hepatology, 27, pp. 957 - 965, http://dx.doi.org/10.1111/j.1440-1746.2011.07035.x

Piraino BF; Vollmer-Conna US; Lloyd AR, 2012, 'Genetic associations of fatigue and other symptom domains of the acute sickness response to infection', Brain Behavior and Immunity, 26, pp. 552 - 558, http://dx.doi.org/10.1016/j.bbi.2011.12.009

Grebely J; Prins M; Hellard M; Cox AL; Osburn WO; Lauer G; Page K; Lloyd AR; Dore GJ; Maher L, 2012, 'Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine', Lancet Infectious Diseases, 12, pp. 408 - 414, http://dx.doi.org/10.1016/S1473-3099(12)70010-5

Grebely J; Pham ST; Matthews G; Petoumenos K; Bull RA; Yeung B; Rawlinson WD; Kaldor JM; Lloyd AR; Hellard M; Dore GJ; White PA; Bull ; Dolan K, 2012, 'Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infection', Hepatology, 55, pp. 1058 - 1069, http://dx.doi.org/10.1002/hep.24754

Flynn J; Dore GJ; Matthews G; Hellard M; Yeung B; Rawlinson W; White PA; Kaldor JM; Lloyd AR; Ffrench RA; Dolan K, 2012, 'Impaired hepatitis C virus (HCV)-specific interferon-responses in individuals with HIV who acquire HCV infection: Correlation with CD4 + T-cell counts', Journal of Infectious Diseases, 206, pp. 1568 - 1576, http://dx.doi.org/10.1093/infdis/jis544

Luciani F; Bull RA; Lloyd AR; Bull , 2012, 'Next generation deep sequencing and vaccine design: Today and tomorrow', Trends in Biotechnology, 30, pp. 443 - 452, http://dx.doi.org/10.1016/j.tibtech.2012.05.005

Ahmadzai H; Cameron B; Chui JJ; Lloyd A; Wakefield D; Thomas PS, 2012, 'Peripheral blood responses to specific antigens and CD28 in sarcoidosis', Respir Med, 106, pp. 701 - 709, http://dx.doi.org/10.1016/j.rmed.2012.01.012

Beaumont A; Burton AR; Lemon JA; Bennett BK; Lloyd AR; Vollmer-Conna US, 2012, 'Reduced Cardiac Vagal Modulation Impacts on Cognitive Performance in Chronic Fatigue Syndrome', PLoS One, 7, pp. e49518, http://dx.doi.org/10.1371/journal.pone.0049518

Grebely J; Hellard M; Applegate TL; Petoumenos K; Yeung B; Feld J; Rawlinson WD; Lloyd AR; George J; Kaldor JM; Dore GJ; Matthews G; Dolan K, 2012, 'Virological responses during treatment for recent hepatitis C virus: Potential benefit for ribavirin use in HCV/HIV co-infection', AIDS, 26, pp. 1653 - 1661, http://dx.doi.org/10.1097/QAD.0b013e3283553719

Webber K; Mok K; Bennett BK; Juraskova I; Goldstein D; Friedlander M; Lloyd AR; FOLCAN study group , 2011, 'Cancer-related fatigue and sexual functioning in women with early breast cancer: Is there a link?', J Clin Oncol, 29, pp. 9072, http://www.ncbi.nlm.nih.gov/pubmed/28021533

Grebely J; Matthews G; Hellard M; Shaw D; van Beek I; Petoumenos K; Alavi M; Yeung B; Haber P; Lloyd AR; Kaldor JM; Dore GJ; Dolan K, 2011, 'Adherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug users', Journal of Hepatology, 55, pp. 76 - 85, http://dx.doi.org/10.1016/j.jhep.2010.10.033

Cameron B; Emerson C; Workman C; Kelly M; Lloyd A; Post J, 2011, 'Alterations in Immune Function are Associated with Liver Enzyme Elevation in HIV and HCV Co-infection after Commencement of Combination Antiretroviral Therapy', Journal of Clinical Immunology, 31, pp. 1079 - 1083, http://dx.doi.org/10.1007/s10875-011-9587-6

Catano G; Chykarenko ZA; Mangano A; Anaya J-M; He W; Smith A; Bologna R; Sen L; Clark RA; Lloyd AR; Shostakovich-koretskaya R; Ahuja SK, 2011, 'Concordance of CCR5 Genotypes that Influence Cell-Mediated Immunity and HIV-1 Disease Progression Rates', Journal of Infectious Diseases, 203, pp. 263 - 272, http://dx.doi.org/10.1093/infdis/jiq023

Webber K; Mok K; Bennett BK; Lloyd AR; Friedlander M; Juraskova I; Goldstein D, 2011, 'If I Am in the Mood, I Enjoy It: an exploration of cancer-related fatigue and sexual functioning in women with breast cancer', Oncologist, 16, pp. 1333 - 1344

Galbraith S; Cameron B; Li H; Lau D; Vollmer-Conna U; Lloyd AR, 2011, 'Peripheral Blood Gene Expression in Postinfective Fatigue Syndrome Following From Three Different Triggering Infections', Journal of Infectious Diseases, 204, pp. 1632 - 1640, http://dx.doi.org/10.1093/infdis/jir612

Rahman K; Burton AR; Galbraith SA; Lloyd AR; Vollmer-Conna U, 2011, 'Sleep-wake behaviour in chronic fatigue syndrome', Sleep, 34, pp. 671 - 678

Palmer CS; Dehart M; Zhang X; Feilotter H; Lloyd A; Zekry A, 2010, 'miR-135a*plays a key role in regulating lipogenesis and inflammation in liver diseases', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 25, pp. A128 - A128, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000283321200338&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Webber K; Goldstein D; Bennett BK; Boyle FM; De Souza PL; Wilcken N; Friedlander M; Lloyd AR, 2010, 'Influence of fatigue after breast cancer adjuvant theraphy on health care utilization and percieved needs', JOURNAL OF CLINICAL ONCOLOGY, 28, http://dx.doi.org/10.1200/jco.2010.28.15_suppl.9047

Lloyd A; White P; Wessely S; Sharpe M; Buchwald D, 2010, 'Comment on "Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome"', Science, 328, pp. 825, http://dx.doi.org/10.1126/science.1183706

Lloyd A, 2010, 'Halting hepatitis', Australian Life Scientist, 7, pp. 32

Kadota Y; Cooper G; Burton AR; Lemon J; Schall U; Lloyd AROLA; Vollmer-Conna US, 2010, 'Autonomic hyper-vigilance in post-infective fatigue syndrome', Biological Psychology, 85, pp. 97 - 103

Dore GJ; Hellard M; Matthews G; Grebely J; Haber PS; Petoumenos K; Yeung B; Marks P; Van Beek IA; McCaughan G; White PA; French R; Rawlinson WD; Lloyd AROLA; Kaldor JM; Dolan K, 2010, 'Effective treatment of injecting drug users with recently acquired hepatitis C virus infection', Gastroenterology, 138, pp. 123 - 135, http://dx.doi.org/10.1053/j.gastro.2009.09.019

Boonwaat L; Haber PS; Levy M; Lloyd AR, 2010, 'Establishment of a successful assessment and treatment service for Australian prison inmates with chronic hepatitis C', Medical Journal of Australia, 192, pp. 496 - 500

Grebely J; Petoumenos K; Matthews G; Haber PS; Marks P; Lloyd AROLA; Kaldor JM; Dore GJ; Hellard M; Dolan K, 2010, 'Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study', Drug and Alcohol Dependence, 107, pp. 244 - 249, http://dx.doi.org/10.1016/j.drugalcdep.2009.09.015

Pham STP; Bull RA; Bennett JM; Rawlinson WD; Lloyd AR; Dore GJD; White PA; Bull , 2010, 'Frequent multiple hepatitis C virus infections among injection drug users in a prison setting', Hepatology, 52, pp. 1564 - 1572, http://dx.doi.org/10.1002/hep.23885

Dolan K; Teutsch S; Scheuer N; Levy M; Rawlinson WD; Kaldor JM; Lloyd AROLA; Haber P, 2010, 'Incidence and risk for acute hepatitis C infection during imprisonment in Australia', European Journal of Epidemiology, 25, pp. 143 - 148, http://dx.doi.org/10.1007/s10654-009-9421-0

Teutsch S; Luciani F; Scheuer N; McCredie L; Hosseiny P; Rawlinson WD; Kaldor JM; Dore GJ; Dolan K; Ffrench R; Lloyd AROLA; Haber P; Levy MH, 2010, 'Incidence of primary Hepatitis C infection and risk factors for transmission in an Australian prisoner cohort', BMC Public Health, 10, pp. 1 - 9, http://dx.doi.org/10.1186/1471-2458-10-633

Grebely J; Petoumenos K; Hellard M; Matthews G; Suppiah V; Applegate TL; Yeung B; Marks P; Rawlinson WD; Lloyd AROLA; Booth D; Kaldor JM; George J; Dore GJ; Amin J; Cameron B; Acraman B; Dolan K; Bloch M; Van Beek I; Li H; Madden A, 2010, 'Potential Role for Interleukin-28B Genotype in Treatment Decision-Making in Recent Hepatitis C Virus Infection', Hepatology, 52, pp. 1216 - 1224, http://dx.doi.org/10.1002/hep.23850

Burton AR; Rahman K; Kadota Y; Lloyd AROLA; Vollmer-Conna US, 2010, 'Reduced heart rate variability predicts poor sleep quality in a case–control study of chronic fatigue syndrome', Experimental Brain Research, 204, pp. 71 - 78, http://dx.doi.org/10.1007/s00221-010-2296-1

Cameron B; Flamand L; Juwana H; Middeldorp J; Naing Z; Rawlinson W; Ablashi D; Lloyd A, 2010, 'Serological and virological investigation of the role of the herpesviruses EBV, CMV and HHV-6 in post-infective fatigue syndrome', Journal of Medical Virology, 82, pp. 1684 - 1688, http://dx.doi.org/10.1002/jmv.21873

Back to profile page